Clinical Trials Browser

Phase 3 × Terminated × Risedronic Acid × Clear all

NCT00216060 2016-05-26

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Phase 3 Terminated

63 enrolled 19 charts

Prostatic Neoplasms